A4WVE5 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase MolNFT, Molecular NFT on GenesisL1

4-diphosphocytidyl-2-C-methyl-D-erythritol kinase

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeifvis36kvi7o4hwshpsd6siirti5ubviqtz2gpffuzyvja3ueeynu/metadata.json

IPFS of structure file:

bafybeic3ziyu2iibjfclp3eyrjykf3znvjcno5fy3fbkdyz5et3okto5ku/AF-A4WVE5-F1-model_v2.pdb

First NFT owner address (eip-55):

0x6e687cC6e263D2A00FeB863E3480af514fBBF1Bd

First NFT owner address (bech32):

genesis1de58e3hzv0f2qrltsclrfq90298mhudafzyzly

Current NFT ID #193406 owner (web3):

0x8a24CBa3fbFCBbB9686CfD21aB7D75cD5a37f2D0

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
193406
Accession (UniProt):
A4WVE5
Name::
4-diphosphocytidyl-2-C-methyl-D-erythritol kinase
Experimental Method:
Predicted structure
Sequence source:
Cereibacter sphaeroides (strain ATCC 17025 / ATH 2.4.3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A4WVE5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A4WVE5|ISPE_CERS5 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase OS=Cereibacter sphaeroides (strain ATCC 17025 / ATH 2.4.3) OX=349102 GN=ispE PE=3 SV=1 MTEAFARAKINLTLHVTGQRPDGYHLLDSLVVFADVGDRVRTEPAEALSLAITGPQAVNLPVSDDNLVLRAARAMGGQGARITLEKHLPVASGIGGGSADAAATLKALAELWQRPLPEAAAVLRLGADVPVCLEGRAVRMAGVGEILEPLAGPLPPAWLVLANPGVSVPTPPVFKALARRDNPPMPERLPDWGSADELAAFLAAMRNDLEAPAIALAPEVAETRAALAAEPGCLIARMSGSGATCFGLFAEERPARAAAEALRAAHPGWWIEPARMAG

A4WVE5 AF NFT

MOLNFT AF v1

NFT data

MOLNFT A4WVE5 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience